LLY

879.51

-2.09%↓

JNJ

239.74

+0.04%↑

ABBV

209.86

-0.59%↓

NVS

148.06

-1.14%↓

MRK

119.75

+0.73%↑

LLY

879.51

-2.09%↓

JNJ

239.74

+0.04%↑

ABBV

209.86

-0.59%↓

NVS

148.06

-1.14%↓

MRK

119.75

+0.73%↑

LLY

879.51

-2.09%↓

JNJ

239.74

+0.04%↑

ABBV

209.86

-0.59%↓

NVS

148.06

-1.14%↓

MRK

119.75

+0.73%↑

LLY

879.51

-2.09%↓

JNJ

239.74

+0.04%↑

ABBV

209.86

-0.59%↓

NVS

148.06

-1.14%↓

MRK

119.75

+0.73%↑

LLY

879.51

-2.09%↓

JNJ

239.74

+0.04%↑

ABBV

209.86

-0.59%↓

NVS

148.06

-1.14%↓

MRK

119.75

+0.73%↑

Search

Cencora Inc

Open

SectorGezondheidszorg

313.6 -2.25

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

308.95

Max

323.13

Belangrijke statistieken

By Trading Economics

Inkomsten

906M

566M

Verkoop

2.2B

86B

K/W

Sectorgemiddelde

38.442

57.05

EPS

4.08

Dividendrendement

0.69

Winstmarge

0.659

Werknemers

47,000

EBITDA

858M

1B

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+26.57% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.69%

2.52%

Volgende Winsten

6 mei 2026

Volgende dividenddatum

1 jun 2026

Volgende Ex Dividend datum

15 mei 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-8.4B

62B

Vorige openingsprijs

315.85

Vorige sluitingsprijs

313.6

Nieuwssentiment

By Acuity

6%

94%

4 / 349 Rangschikking in Healthcare

Cencora Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

26 mrt 2026, 23:43 UTC

Marktinformatie

Nikkei May Decline Amid Uncertainty Over Iran Peace Talks -- Market Talk

26 mrt 2026, 23:36 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Gold Rises Amid Signs of Easing Middle East Tensions -- Market Talk

26 mrt 2026, 23:35 UTC

Acquisities, Fusies, Overnames

Pernod Ricard: Confirms Discussions With Brown-Forman

26 mrt 2026, 23:29 UTC

Winsten

Haier Smart Home: Company to Finance Share Buybacks Via Internal Funds >600690.SH

26 mrt 2026, 23:28 UTC

Winsten

Haier Smart Home Plans A Share Buybacks of CNY3.0B-CNY6.0B >600690.SH

26 mrt 2026, 23:28 UTC

Winsten

Haier Smart Home Plans to Increase Payout Ratio to 60% for 2027, 2028 >600690.SH

26 mrt 2026, 23:28 UTC

Winsten

Haier Smart Home Plans Cash Dividend Payout Ratio of Up to 58% for 2026 >600690.SH

26 mrt 2026, 23:27 UTC

Winsten

Haier Smart Home 2025 Net CNY19.55B Vs. Net CNY18.73B >600690.SH

26 mrt 2026, 23:27 UTC

Winsten

Haier Smart Home 2025 Rev CNY302.33B Vs. CNY286.01B >600690.SH

26 mrt 2026, 23:08 UTC

Marktinformatie

Infratil's Investor Day Addresses Data-Center Issues -- Market Talk

26 mrt 2026, 23:04 UTC

Acquisities, Fusies, Overnames

Pernod Ricard in Talks to Combine With Jack Daniel's Maker Brown-Forman -- WSJ

26 mrt 2026, 23:04 UTC

Acquisities, Fusies, Overnames

Families Behind Pernod, Brown-Forman Would Each Likely Retain Significant Stakes, Source Says -- WSJ

26 mrt 2026, 23:04 UTC

Acquisities, Fusies, Overnames

Pernod, Brown-Forman Discussing Mostly Stock Deal, Source Says -- WSJ

26 mrt 2026, 23:04 UTC

Acquisities, Fusies, Overnames

Pernod-Brown-Forman Deal Announcement Could Be Weeks Away, Sources Say -- WSJ

26 mrt 2026, 23:04 UTC

Acquisities, Fusies, Overnames

Pernod in Deal Talks With Brown-Forman -- WSJ

26 mrt 2026, 22:41 UTC

Acquisities, Fusies, Overnames

Brown-Forman: No Agreement Has Been Reached as to Terms of Any Possible Pernod Ricard Transaction

26 mrt 2026, 22:41 UTC

Acquisities, Fusies, Overnames

Brown-Forman: Synergies From Contemplated Pernod Ricard Combination Expected to Be Significant

26 mrt 2026, 22:26 UTC

Winsten

Jiangxi Copper 2025 Rev CNY544.62B Vs. CNY516.61B >0358.HK

26 mrt 2026, 22:26 UTC

Winsten

Jiangxi Copper 2025 Net CNY7.13B Vs. Net CNY6.96B >0358.HK

26 mrt 2026, 22:26 UTC

Winsten

Jiangxi Copper Higher Demand For Products Supported Results>0358.HK

26 mrt 2026, 22:08 UTC

Winsten

Air China 2025 Loss CNY1.79B Vs. Loss CNY232.56M >0753.HK

26 mrt 2026, 22:08 UTC

Winsten

Air China Impairment Loss on Goodwill Weighed on Results>0753.HK

26 mrt 2026, 22:08 UTC

Winsten

Air China 2025 Rev CNY171.48B Vs. CNY166.70B >0753.HK

26 mrt 2026, 22:07 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Global Energy Roundup: Market Talk

26 mrt 2026, 22:07 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Open-Pit Gold Miners Most Exposed to High Fuel Prices -- Market Talk

26 mrt 2026, 22:00 UTC

Winsten

Tsingtao Brewery 2025 Net CNY4.59B Vs. Net CNY4.34B >0168.HK

26 mrt 2026, 22:00 UTC

Winsten

Tsingtao Brewery: Higher Volume Sales of Beer Supported Results>0168.HK

26 mrt 2026, 22:00 UTC

Winsten

Tsingtao Brewery 2025 Rev CNY32.47B Vs. CNY32.14B >0168.HK

26 mrt 2026, 21:39 UTC

Acquisities, Fusies, Overnames

BlueScope: Sees Early Indications of Strong Interest in Site Adjacent Western Port

26 mrt 2026, 21:38 UTC

Acquisities, Fusies, Overnames

BlueScope: Has Begun Expression of Interest Process For 65-Hectare Site Adjacent Western Port

Peer Vergelijking

Prijswijziging

Cencora Inc Prognose

Koersdoel

By TipRanks

26.57% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 411.44 USD  26.57%

Hoogste 440 USD

Laagste 380 USD

Gebaseerd op 10 Wall Street-analisten die 12-maands prijsdoelen bieden voor Cencora Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

10 ratings

9

Buy

1

Hold

0

Sell

Sentiment

By Acuity

4 / 349 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat